Literature DB >> 2502059

Alpha-interferon for severe cold agglutinin disease.

B M O'Connor1, J S Clifford, W D Lawrence, G L Logue.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2502059     DOI： 10.7326/0003-4819-111-3-255

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  8 in total

Review 1.  Interferons 1992. How much of the promise has been realised?

Authors:  M A Volz; C H Kirkpatrick
Journal:  Drugs       Date:  1992-03       Impact factor: 9.546

2.  Low-dose interferon-alpha in stage-I multiple myeloma and in IgM monoclonal gammopathy. Eastern Cooperative Study Group on Monoclonal Gammopathies.

Authors: 
Journal:  Ann Hematol       Date:  1992-03       Impact factor: 3.673

Review 3.  Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review.

Authors:  Peter Valent; Klaus Lechner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 4.  Autoimmune hemolytic anemia.

Authors:  B Agarwal
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

5.  Successful response to alpha-interferon 2b in a refractory IgM autoagglutinin-mediated hemolytic anemia.

Authors:  T Fest; B de Wazières; B Lamy; M Maskani; D Vuitton; J L Dupond
Journal:  Ann Hematol       Date:  1994-09       Impact factor: 3.673

Review 6.  Autoimmune hemolytic anemia: From lab to bedside.

Authors:  R K Chaudhary; Sudipta Sekhar Das
Journal:  Asian J Transfus Sci       Date:  2014-01

Review 7.  New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia.

Authors:  Sigbjørn Berentsen
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

Review 8.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.